journal article·2021-01-26

3D Microfluidic Platform and Tumor Vascular Mapping for Evaluating Anti-Angiogenic RNAi-Based Nanomedicine

Somin Lee, Seongchan Kim, Dong-Jun Koo, James Yu, Hyeongjun Cho, Hyojin Lee, Joon Myong Song, Sung-Yon Kim, Dal-Hee Min, Noo Li Jeon

ACS Nano· Volume 15· Issue 1
Publisher page

Abstract

Three-dimensional (3D) visualization of tumor vasculature is a key factor in accurate evaluation of RNA interference (RNAi)-based antiangiogenic nanomedicine, a promising approach for cancer therapeutics. However, this remains challenging because there is not a physiologically relevant in vitro model or precise analytic methodology. To address this limitation, a strategy based on 3D microfluidic angiogenesis-on-a-chip and 3D tumor vascular mapping was developed for evaluating RNAi-based antiangiogenic nanomedicine. We developed a microfluidic model to recapitulate functional 3D angiogenic sprouting when co-cultured with various cancer cell types. This model enabled efficient and rapid assessment of antiangiogenic nanomedicine in treatment of hyper-angiogenic cancer. In addition, tissue-clearing-based whole vascular mapping of tumor xenograft allowed extraction of complex 3D morphological information in diverse quantitative parameters. Using this 3D imaging-based analysis, we observed tumor sub-regional differences in the antiangiogenic effect. Our systematic strategy can help in narrowing down the promising targets of antiangiogenic nanomedicine and then enables deep analysis of complex morphological changes in tumor vasculature, providing a powerful platform for the development of safe and effective nanomedicine for cancer therapeutics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Angiogenesis and VEGF in Cancer · 3D Printing in Biomedical Research · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Interdisciplinary Program in Bioengineering, Seoul National University, Seoul 08826, Republic of Korea

Department of Chemistry, Seoul National University, Seoul 08826, Republic of Korea

Program in Neuroscience, Seoul National University, Seoul 08826, Republic of Korea

Biomaterials Research Center, Biomedical Research Division, Korea Institute of Science and Technology, 5 Hwarangno 14-gil, Seongbuk-gu, Seoul 02792, Republic of Korea

College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea

Institute of Biotherapeutics Convergence Technology, Lemonex Inc., Seoul 08826, Republic of Korea

Department of Mechanical Engineering, Seoul National University, Seoul 08826, Republic of Korea

Institute of Advanced Machines and Design, Seoul National University, Seoul 08826, Republic of Korea

Funding

Korea Health Industry Development Institute · National Research Foundation of Korea

References (82)

Show source-provided references
1. 10.1038/3502522010.1038/35025220 ↗
2. 10.1093/jnci/82.1.410.1093/jnci/82.1.4 ↗
3. 10.1016/j.canlet.2012.03.00810.1016/j.canlet.2012.03.008 ↗
4. 10.1038/nm.253710.1038/nm.2537 ↗
5. 10.1158/0008-5472.CAN-11-340610.1158/0008-5472.CAN-11-3406 ↗
6. 10.1038/nrd138110.1038/nrd1381 ↗
7. 10.1016/j.bbrc.2005.05.13210.1016/j.bbrc.2005.05.132 ↗
8. 10.1038/nature0448310.1038/nature04483 ↗
9. 10.1038/nchembio83910.1038/nchembio839 ↗
10. 10.1038/3588810.1038/35888 ↗
11. 10.1021/acsnano.6b0719510.1021/acsnano.6b07195 ↗
12. 10.1073/pnas.171956511510.1073/pnas.1719565115 ↗
13. 10.1158/0008-5472.CAN-03-268210.1158/0008-5472.CAN-03-2682 ↗
14. 10.1016/j.jconrel.2012.05.00510.1016/j.jconrel.2012.05.005 ↗
15. 10.1016/j.ejps.2017.10.03610.1016/j.ejps.2017.10.036 ↗
16. 10.1016/j.ymthe.2006.03.02210.1016/j.ymthe.2006.03.022 ↗
17. 10.1007/s12274-016-1309-110.1007/s12274-016-1309-1 ↗
18. 10.3390/ijms2102045510.3390/ijms21020455 ↗
19. 10.1089/ars.2017.738310.1089/ars.2017.7383 ↗
20. 10.1039/C9LC00148D10.1039/C9LC00148D ↗
21. 10.1039/C8LC00285A10.1039/C8LC00285A ↗
22. 10.1039/C9LC00140A10.1039/C9LC00140A ↗
23. 10.1002/adhm.20170019610.1002/adhm.201700196 ↗
24. 10.1016/j.biomaterials.2019.11954710.1016/j.biomaterials.2019.119547 ↗
25. 10.1039/C4LC00866A10.1039/C4LC00866A ↗
26. 10.1021/acsnano.9b0068610.1021/acsnano.9b00686 ↗
27. 10.1021/acsnano.7b0082410.1021/acsnano.7b00824 ↗
28. 10.1039/C6LC00910G10.1039/C6LC00910G ↗
29. 10.1021/acsnano.8b0684610.1021/acsnano.8b06846 ↗
30. 10.1109/TNANO.2017.277142610.1109/TNANO.2017.2771426 ↗
31. 10.1039/c3lc41320a10.1039/c3lc41320a ↗
32. 10.1242/jcs.11639210.1242/jcs.116392 ↗
33. 10.1016/j.jconrel.2013.10.00310.1016/j.jconrel.2013.10.003 ↗
34. 10.1038/nm.197110.1038/nm.1971 ↗
35. 10.1593/neo.13184810.1593/neo.131848 ↗
36. 10.1021/acs.nanolett.9b0485310.1021/acs.nanolett.9b04853 ↗
37. 10.1021/acsnano.8b0390010.1021/acsnano.8b03900 ↗
38. 10.1021/nn800052e10.1021/nn800052e ↗
39. 10.2903/j.efsa.2018.508810.2903/j.efsa.2018.5088 ↗
40. 10.3390/pharmaceutics1205043210.3390/pharmaceutics12050432 ↗
41. 10.1039/C5RA27777A10.1039/C5RA27777A ↗
42. 10.1002/smll.20120002810.1002/smll.201200028 ↗
43. 10.1038/cr.2011.19810.1038/cr.2011.198 ↗
44. 10.1161/01.RES.0000259593.07661.1e10.1161/01.RES.0000259593.07661.1e ↗
45. 10.1016/j.jconrel.2010.08.02710.1016/j.jconrel.2010.08.027 ↗
46. 10.1016/j.addr.2018.04.00110.1016/j.addr.2018.04.001 ↗
47. 10.1038/nature0447810.1038/nature04478 ↗
48. Eberhard A. · Cancer Res. · 2000 · 60 · 1388
49. 10.1023/A:102651013011410.1023/A:1026510130114 ↗
50. 10.1007/s00280-013-2298-310.1007/s00280-013-2298-3 ↗
51. 10.1007/s00432-003-0530-y10.1007/s00432-003-0530-y ↗
52. 10.1126/science.118830210.1126/science.1188302 ↗
53. 10.1126/science.121781510.1126/science.1217815 ↗
54. 10.1371/journal.pone.015036010.1371/journal.pone.0150360 ↗
55. 10.1016/j.celrep.2017.09.04310.1016/j.celrep.2017.09.043 ↗
56. 10.1038/s41467-019-10588-010.1038/s41467-019-10588-0 ↗
57. 10.1038/srep3158910.1038/srep31589 ↗
58. 10.1039/C6LC01422D10.1039/C6LC01422D ↗
59. 10.1007/s40883-018-0054-210.1007/s40883-018-0054-2 ↗
60. 10.1002/adfm.20200244410.1002/adfm.202002444 ↗
61. 10.1039/c2ib00184e10.1039/c2ib00184e ↗
62. 10.1002/bit.2722410.1002/bit.27224 ↗
63. 10.1126/science.110481910.1126/science.1104819 ↗
64. 10.1038/nrclinonc.2010.13910.1038/nrclinonc.2010.139 ↗
65. 10.1016/j.jconrel.2015.04.00610.1016/j.jconrel.2015.04.006 ↗
66. 10.1038/sj.bjc.660492910.1038/sj.bjc.6604929 ↗
67. 10.1007/s10555-007-9094-710.1007/s10555-007-9094-7 ↗
68. 10.1038/nrc.2017.9310.1038/nrc.2017.93 ↗
69. 10.1038/nrclinonc.2010.13910.1038/nrclinonc.2010.139 ↗
70. 10.1158/0008-5472.CAN-04-007410.1158/0008-5472.CAN-04-0074 ↗
71. 10.1021/acsnano.5b0202810.1021/acsnano.5b02028 ↗
72. 10.1002/advs.20180207010.1002/advs.201802070 ↗
73. 10.1146/annurev-physiol-020518-11470010.1146/annurev-physiol-020518-114700 ↗
74. 10.1016/j.biomaterials.2016.01.06810.1016/j.biomaterials.2016.01.068 ↗
75. 10.1038/mtna.2016.9010.1038/mtna.2016.90 ↗
76. 10.1083/jcb.20140810310.1083/jcb.201408103 ↗
77. 10.1016/j.isci.2018.12.00510.1016/j.isci.2018.12.005 ↗
78. 10.1038/ncomms1515810.1038/ncomms15158 ↗
79. 10.1016/j.febslet.2013.05.03810.1016/j.febslet.2013.05.038 ↗
80. 10.1016/j.chembiol.2015.11.00910.1016/j.chembiol.2015.11.009 ↗
81. 10.1371/journal.pone.002738510.1371/journal.pone.0027385 ↗
82. 10.1021/acs.bioconjchem.0c0026310.1021/acs.bioconjchem.0c00263 ↗